Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Chessa

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Blood|September 15, 1995
TCL1 oncogene activation in preleukemic T cells from a case of ataxia-telangiectasiaM G Narducci, L Virgilio, M Isobe, et al.
Il Giornale Di Chirurgia|November 25, 2004
[Cystic lymphangioma of the adult: our experience and review of literature]D Cavaliere, D Ghinolfi, G V Tommasi, et al.
American Journal of Human Genetics|May 20, 1999
Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequencesS N Teraoka, M Telatar, S Becker-Catania, et al.
European Review for Medical and Pharmacological Sciences|September 5, 2023
Comparing the responses of countries and National Health Systems to the COVID-19 pandemic: a critical analysis with a case-report seriesM G Carta, G Orrù, R Littera, et al.
Molecular Genetics and Metabolism|June 30, 2000
Ataxia-telangiectasia: phenotype/genotype studies of ATM protein expression, mutations, and radiosensitivityS G Becker-Catania, G Chen, M J Hwang, et al.
Human Mutation|February 5, 1998
Identification of ATM mutations using extended RT-PCR and restriction endonuclease fingerprinting, and elucidation of the repertoire of A-T mutations in IsraelS Gilad, R Khosravi, R Harnik, et al.
British Journal of Cancer|June 23, 2000
ATM protein and p53-serine 15 phosphorylation in ataxia-telangiectasia (AT) patients and at heterozygotesD Delia, S Mizutani, S Panigone, et al.
Molecular and Cellular Biology|July 5, 2001
Chk2 activation dependence on Nbs1 after DNA damageG Buscemi, C Savio, L Zannini, et al.
Human Molecular Genetics|May 24, 2001
hMRE11: genomic structure and a null mutation identified in a transcript protected from nonsense-mediated mRNA decayS A Pitts, H S Kullar, T Stankovic, et al.
Medical Hypotheses|October 29, 1998
Congenital disorders sharing oxidative stress and cancer proneness as phenotypic hallmarks: prospects for joint research in pharmacologyG Pagano, L G Korkina, U T Brunk, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Blood|September 15, 1995
TCL1 oncogene activation in preleukemic T cells from a case of ataxia-telangiectasiaM G Narducci, L Virgilio, M Isobe, et al.
Il Giornale Di Chirurgia|November 25, 2004
[Cystic lymphangioma of the adult: our experience and review of literature]D Cavaliere, D Ghinolfi, G V Tommasi, et al.
American Journal of Human Genetics|May 20, 1999
Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequencesS N Teraoka, M Telatar, S Becker-Catania, et al.
European Review for Medical and Pharmacological Sciences|September 5, 2023
Comparing the responses of countries and National Health Systems to the COVID-19 pandemic: a critical analysis with a case-report seriesM G Carta, G Orrù, R Littera, et al.
Molecular Genetics and Metabolism|June 30, 2000
Ataxia-telangiectasia: phenotype/genotype studies of ATM protein expression, mutations, and radiosensitivityS G Becker-Catania, G Chen, M J Hwang, et al.
Human Mutation|February 5, 1998
Identification of ATM mutations using extended RT-PCR and restriction endonuclease fingerprinting, and elucidation of the repertoire of A-T mutations in IsraelS Gilad, R Khosravi, R Harnik, et al.
British Journal of Cancer|June 23, 2000
ATM protein and p53-serine 15 phosphorylation in ataxia-telangiectasia (AT) patients and at heterozygotesD Delia, S Mizutani, S Panigone, et al.
Molecular and Cellular Biology|July 5, 2001
Chk2 activation dependence on Nbs1 after DNA damageG Buscemi, C Savio, L Zannini, et al.
Human Molecular Genetics|May 24, 2001
hMRE11: genomic structure and a null mutation identified in a transcript protected from nonsense-mediated mRNA decayS A Pitts, H S Kullar, T Stankovic, et al.
Medical Hypotheses|October 29, 1998
Congenital disorders sharing oxidative stress and cancer proneness as phenotypic hallmarks: prospects for joint research in pharmacologyG Pagano, L G Korkina, U T Brunk, et al.
Pageof 9